Prostatype Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Prostatype Genomics's estimated annual revenue is currently $4.5M per year.
- Prostatype Genomics's estimated revenue per employee is $251,000
Employee Data
- Prostatype Genomics has 18 Employees.
- Prostatype Genomics grew their employee count by 38% last year.
Prostatype Genomics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Communications Director | Reveal Email/Phone |
2 | Market Development Senior Director - Italy | Reveal Email/Phone |
3 | President - US Operations | Reveal Email/Phone |
Prostatype Genomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 56 | -10% | N/A | N/A |
#2 | $4M | 16 | -43% | N/A | N/A |
#3 | $8M | 32 | 33% | N/A | N/A |
#4 | $44.2M | 176 | -5% | N/A | N/A |
#5 | $100.4M | 400 | 8% | N/A | N/A |
#6 | $4.5M | 18 | 38% | N/A | N/A |
#7 | $5.5M | 22 | 5% | N/A | N/A |
What Is Prostatype Genomics?
Prostatype Genomics offers prostate cancer patients a decision support for the most optimal treatment option! We developed a test system called 'Prostatype® Test System'. The system is based on a gene expression test, which measures the expression of three carefully selected embryonic stem cell genes in prostate cancer core needle biopsies. In conjunction with currently used clinical parameters, the PrTS predicts overall survival in relation to treatment. The Prostatype® Test System helps to choose the optimal treatment strategy for each patient. This secures quality of life for patients with a low risk tumor without jeopardizing safety for patients with aggressive tumors.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$4.5M
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Prostatype Genomics News
Redeye ser ett omfattande behov av medicinteknikbolaget Prostatype Genomics prognostest som stöder det avgörande beslutet av behandling av...
Medicinteknikbolaget Prostatype Genomics har inlett samarbete med Capio Specialistcenter i Solna, enligt ett pressmeddelande. Detta samarbete innebär att...
Redeye initiates coverage of Prostatype Genomics, a company offering a prognostics test that supports the critical decision by prostate cancer (PCa) patients...
Other Companies in Stockholm
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 18 | -10% | N/A |
#2 | N/A | 18 | -25% | N/A |
#3 | $1.7M | 18 | -25% | N/A |
#4 | $1.7M | 18 | 29% | N/A |
#5 | $1.6M | 18 | -10% | N/A |